Last reviewed · How we verify
Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients Pre and Post Treatment With Olopatadine HCL Ophthalmic Solution, 0.2%
The purpose of this study is to descriptively evaluate the corneal structures of allergic conjunctivitis patients.
Details
| Lead sponsor | Alcon Research |
|---|---|
| Phase | Phase 4 |
| Status | COMPLETED |
| Enrolment | 17 |
| Start date | 2012-09 |
| Completion | 2013-07 |
Conditions
- Allergic Conjunctivitis
Interventions
- Olopatadine hydrochloride ophthalmic solution, 0.2%
Primary outcomes
- Patient-Assessed Ocular Itching — Baseline (Day 1), Day 14
The patient rated the severity of ocular itching using a predetermined 0-4 scale, where 0=none and 4=severe itching with irresistible urge to rub. Each eye was rated separately. A 2-week washout period from prior allergy medication (if applicable) preceded the baseline assessment.
Countries
United States